Thank you.
I think the key to that is the risk-based approach. When we allow and provide the support for the departments to complete risk-based oversight of new products when they deem necessary, that's what creates that balance of ensuring that it's a robust, science-based decision that determines whether a product is or is not suitable and how, and the limitations to which it's used.
As a short answer, I really think that maintaining a very risk-based approach and avoiding a hazard-based approach is critical to having that balance.